Heron Therapeutics Inc. (HRTX) on Monday reported a loss of $43.2 million in its second quarter.
On a per-share basis, the Redwood City, California-based company said it had a loss of $1.17.
The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 96 cents per share.
Heron Therapeutics shares have fallen 30 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $18.74, a fall of 40 percent in the last 12 months.
On a per-share basis, the Redwood City, California-based company said it had a loss of $1.17.
The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 96 cents per share.
Heron Therapeutics shares have fallen 30 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $18.74, a fall of 40 percent in the last 12 months.